FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020148058> ?p ?o ?g. }

• W2020148058 endingPage "410" @default.
• W2020148058 startingPage "410" @default.
• W2020148058 abstract "Symptomatic vulvovaginal candidiasis (VVC) is one of the most common problems leading women to seek advice in primary healthcare facilities.The aim of this study is to describe the associations between some hypothesized factors and the presence of symptomatic VVC.An analytical cross-sectional study was conducted. A total of 90 women diagnosed with symptomatic VVC and 108 women without symptomatic VVC were recruited when attending Umlazi D clinic, a primary health clinic in KwaZulu-Natal, South Africa between June 2011 and December 2011. Confirmed symptomatic VVC was determined by Gram stain and microbiological culture of vaginal swabs. For human immunodeficiency virus (HIV)-infected women, HIV ribonucleic acid load in plasma and genital fluid was determined by real-time-polymerase chain reaction (BioMerieux, Lyon, France). CD4 counts were obtained from patients' medical records. Data were analyzed using the statistical package for the social sciences (SPSS) version 21.0 (SPSS Inc.; Chicago, IL, USA). Multiple logistic regression models were used to exclude univariate confounders. All tests were two-sided and a P < 0.05 was considered to be significant.A total of 90% (81/90) of patients with symptomatic VVC complained of vulval itching, soreness and vaginal discharge when compared to 75.9% (82/108) of patients without symptomatic VVC (P < 0.01). Whilst pregnancy was independently associated with symptomatic VVC (P < 0.01), the latter was inversely related to Nugent's scores (P < 0.01). When compared with HIV negative women, the odds for symptomatic VVC increased among women with HIV-associated immunocompromise (CD4 counts < 200 cells/mm(3), P < 0.001), significantly shedding HIV in their genital tracts (P = 0.04), with plasma HIV load > 1000 copies/mL (P < 0.001). There was a significant negative association between the use of highly active anti-retroviral therapy and the presence of symptomatic VVC in HIV-infected women (P < 0.01).Although symptomatic VVC is not classified as acquired immunodeficiency syndrome-related condition, HIV-related immune compromised women and particularly those who are anti-retroviral therapy-naïve are likely to develop symptomatic VVC." @default.
• W2020148058 created "2016-06-24" @default.
• W2020148058 creator A5030189452 @default.
• W2020148058 creator A5062134788 @default.
• W2020148058 creator A5066267505 @default.
• W2020148058 creator A5083589204 @default.
• W2020148058 creator A5090941935 @default.
• W2020148058 date "2014-01-01" @default.
• W2020148058 modified "2023-09-26" @default.
• W2020148058 title "Factors associated with symptomatic vulvovaginal candidiasis: A study among women attending a primary healthcare clinic in Kwazulu-Natal, South Africa" @default.
• W2020148058 cites W148073127 @default.
• W2020148058 cites W1521540681 @default.
• W2020148058 cites W1595811029 @default.
• W2020148058 cites W1662928676 @default.
• W2020148058 cites W2002572654 @default.
• W2020148058 cites W2005069634 @default.
• W2020148058 cites W2012860919 @default.
• W2020148058 cites W2019393533 @default.
• W2020148058 cites W2027843349 @default.
• W2020148058 cites W2033217017 @default.
• W2020148058 cites W2057389492 @default.
• W2020148058 cites W2066042158 @default.
• W2020148058 cites W2098329206 @default.
• W2020148058 cites W2099029187 @default.
• W2020148058 cites W2101952138 @default.
• W2020148058 cites W2103730621 @default.
• W2020148058 cites W2112804729 @default.
• W2020148058 cites W2113409182 @default.
• W2020148058 cites W2115605871 @default.
• W2020148058 cites W2115801155 @default.
• W2020148058 cites W2124826696 @default.
• W2020148058 cites W2126536749 @default.
• W2020148058 cites W2138563555 @default.
• W2020148058 cites W2147154433 @default.
• W2020148058 cites W2168571032 @default.
• W2020148058 cites W2171952797 @default.
• W2020148058 doi "https://doi.org/10.4103/2141-9248.133470" @default.
• W2020148058 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4071743" @default.
• W2020148058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24971218" @default.
• W2020148058 hasPublicationYear "2014" @default.
• W2020148058 type Work @default.
• W2020148058 sameAs 2020148058 @default.
• W2020148058 citedByCount "21" @default.
• W2020148058 countsByYear W20201480582015 @default.
• W2020148058 countsByYear W20201480582016 @default.
• W2020148058 countsByYear W20201480582017 @default.
• W2020148058 countsByYear W20201480582018 @default.
• W2020148058 countsByYear W20201480582019 @default.
• W2020148058 countsByYear W20201480582020 @default.
• W2020148058 countsByYear W20201480582021 @default.
• W2020148058 countsByYear W20201480582022 @default.
• W2020148058 countsByYear W20201480582023 @default.
• W2020148058 crossrefType "journal-article" @default.
• W2020148058 hasAuthorship W2020148058A5030189452 @default.
• W2020148058 hasAuthorship W2020148058A5062134788 @default.
• W2020148058 hasAuthorship W2020148058A5066267505 @default.
• W2020148058 hasAuthorship W2020148058A5083589204 @default.
• W2020148058 hasAuthorship W2020148058A5090941935 @default.
• W2020148058 hasBestOaLocation W20201480582 @default.
• W2020148058 hasConcept C126322002 @default.
• W2020148058 hasConcept C131872663 @default.
• W2020148058 hasConcept C144301174 @default.
• W2020148058 hasConcept C151956035 @default.
• W2020148058 hasConcept C156957248 @default.
• W2020148058 hasConcept C16005928 @default.
• W2020148058 hasConcept C195910791 @default.
• W2020148058 hasConcept C2776393945 @default.
• W2020148058 hasConcept C2779234561 @default.
• W2020148058 hasConcept C2779548794 @default.
• W2020148058 hasConcept C2779923671 @default.
• W2020148058 hasConcept C2910082039 @default.
• W2020148058 hasConcept C38180746 @default.
• W2020148058 hasConcept C54355233 @default.
• W2020148058 hasConcept C65409693 @default.
• W2020148058 hasConcept C71924100 @default.
• W2020148058 hasConcept C77350462 @default.
• W2020148058 hasConcept C86803240 @default.
• W2020148058 hasConceptScore W2020148058C126322002 @default.
• W2020148058 hasConceptScore W2020148058C131872663 @default.
• W2020148058 hasConceptScore W2020148058C144301174 @default.
• W2020148058 hasConceptScore W2020148058C151956035 @default.
• W2020148058 hasConceptScore W2020148058C156957248 @default.
• W2020148058 hasConceptScore W2020148058C16005928 @default.
• W2020148058 hasConceptScore W2020148058C195910791 @default.
• W2020148058 hasConceptScore W2020148058C2776393945 @default.
• W2020148058 hasConceptScore W2020148058C2779234561 @default.
• W2020148058 hasConceptScore W2020148058C2779548794 @default.
• W2020148058 hasConceptScore W2020148058C2779923671 @default.
• W2020148058 hasConceptScore W2020148058C2910082039 @default.
• W2020148058 hasConceptScore W2020148058C38180746 @default.
• W2020148058 hasConceptScore W2020148058C54355233 @default.
• W2020148058 hasConceptScore W2020148058C65409693 @default.
• W2020148058 hasConceptScore W2020148058C71924100 @default.
• W2020148058 hasConceptScore W2020148058C77350462 @default.
• W2020148058 hasConceptScore W2020148058C86803240 @default.
• W2020148058 hasIssue "3" @default.
• W2020148058 hasLocation W20201480581 @default.
• W2020148058 hasLocation W20201480582 @default.

• next